GlassScriptPhysician profile
Sharif A Ali
NPI 1043417728
$1,352.12
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
See the full distribution for Anatomic Pathology & Clinical Pathology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,012 · 2020: $155 · 2021: $101 · 2022: $59.45 · 2024: $25.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $25.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $25.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $949.94 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $120.00 | 2020 | |
| Foundation Medicine, INC. | $92.06 | 2019-2020 | |
| Roche Diagnostics Corporation | $53.47 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $28.01 | 2021 | |
| Blueprint Medicines Corporation | $25.54 | 2024 | |
| Novartis Pharmaceuticals Corporation | $23.03 | 2019 | |
| Lilly USA, LLC | $20.88 | 2021 | |
| Incyte Corporation | $19.85 | 2019 | |
| Beckman Coulter, INC. | $19.34 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharif Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.